APUS · Apimeds Pharmaceuticals US, Inc. · Documents
$1.81
+0.14 (+8.38%)
At close · Sep 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.47M
Shares
1.51M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-11 | 2026-09-10 | |
| 8-K | 2026-08-21 | 2026-08-19 | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-06 | 2026-08-05 | |
| 8-K | 2026-07-13 | — | |
| 10-Q | 2026-05-26 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| 10-K | 2026-05-04 | 2025-12-31 | |
| 8-K | 2026-05-04 | 2026-04-24 | |
| 8-K | 2026-04-22 | 2026-04-17 | |
| 8-K | 2026-04-16 | 2026-04-15 | |
| 8-K/A | 2026-04-09 | 2026-03-20 | |
| 8-K | 2026-03-26 | 2026-03-20 | |
| 8-K | 2026-03-25 | 2026-03-20 | |
| 8-K | 2026-03-16 | — | |
| 8-K/A | 2026-02-17 | 2025-12-01 | |
| 8-K | 2026-01-02 | 2025-12-30 | |
| 8-K | 2025-12-10 | 2025-12-05 | |
| 8-K/A | 2025-12-10 | 2025-12-01 | |
| 8-K | 2025-12-02 | 2025-12-01 | |
| 8-K | 2025-11-18 | 2025-11-13 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-16 | 2025-10-15 | |
| 10-Q | 2025-08-19 | 2025-06-30 | |
| 8-K | 2025-07-16 | 2025-07-15 | |
| 8-K | 2025-06-05 | 2025-05-30 | |
| 8-K | 2025-05-20 | 2025-05-16 | |
| 10-Q | 2025-05-20 | 2025-03-31 | |
| 8-K | 2025-05-12 | 2025-05-08 | |
| 10-K/A | 2025-05-02 | 2024-12-31 | |
| 8-K | 2025-04-15 | 2025-04-11 | |
| 10-K | 2025-04-15 | 2024-12-31 |
Showing 1–32 of 32 filings